Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.49 |
| ▸ | CYP2A13 | Q16696 | 4/20 | 0.47 |
| ▸ | NCF1 | P14598 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL798244 | 0.89 | HRH3 (0.49) | HRH3MAPTSMN1; SMN2CXCR4CYP2A13 | |
| SCHEMBL20908819 | 0.89 | CNR2 (0.51) | HRH3MAPTSMN1; SMN2CXCR4CYP2A13 | |
| SCHEMBL31703257 | 0.85 | HRH3 (0.45) | HRH3MAPTSMN1; SMN2CXCR4CYP2A13 | |
| SCHEMBL32661873 | 0.82 | HRH3 (0.56) | HRH3SMN1; SMN2CXCR4NCF1ALDH1A1 | |
| SCHEMBL6033570 | 0.81 | CXCR4 (0.49) | HRH3MAPTSMN1; SMN2CXCR4CYP2A13 | |
| SCHEMBL937665 | 0.80 | HRH3 (0.54) | HRH3SMN1; SMN2CYP2A13NCF1ALDH1A1 | |
| SCHEMBL13032564 | 0.78 | HRH3 (0.56) | HRH3MAPTSMN1; SMN2CYP2A13NCF1 | |
| SCHEMBL21792875 | 0.78 | SIGMAR1 (0.56) | HRH3CXCR4MEN1KMT2ASIGMAR1 | |
| SCHEMBL20908520 | 0.78 | MC4R (0.56) | MAPTNCF1ALDH1A1LMNANPC1 | |
| SCHEMBL793723 | 0.78 | HRH3 (0.52) | HRH3MAPTSMN1; SMN2CXCR4NCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4643954-A2 | NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Daewoong Pharmaceutical Co., Ltd. (KR) | 2025-11-05 | — | — | EP | disclosed |
| US-12227498-B2 | Heterocyclic amine derivative and pharmaceutical composition comprising same | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2025-02-18 | — | — | US | disclosed |
| CN-115151537-B | Process for preparing heterocyclic amine derivatives | 株式会社大熊制药 | 2024-09-06 | — | — | CN | disclosed |
| CN-112638910-B | New heterocyclic amine derivatives and pharmaceutical compositions containing the same | 株式会社大熊制药 | 2024-06-11 | — | — | CN | disclosed |
| US-20230094404-A1 | METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2023-03-30 | — | — | US | disclosed |
| US-20230094404-A1 | METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2023-03-30 | — | — | US | disclosed |
| EP-4112617-A1 | METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES | Daewoong Pharmaceutical Co., Ltd. (KR) | 2023-01-04 | — | — | EP | disclosed |
| EP-4112617-A1 | METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES | Daewoong Pharmaceutical Co., Ltd. (KR) | 2023-01-04 | — | — | EP | disclosed |
| CN-115151537-A | Process for preparing heterocyclic amine derivatives | 株式会社大熊制药 | 2022-10-04 | — | — | CN | disclosed |
| CN-111212833-B | Phenylpyridine derivatives and pharmaceutical compositions containing the same | 株式会社大熊制药 | 2022-09-06 | — | — | CN | disclosed |
| EP-3696176-A1 | NOVEL PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Daewoong Pharmaceutical Co., Ltd. (KR) | 2020-08-19 | — | — | EP | disclosed |
| US-20200223821-A1 | Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2020-07-16 | — | — | US | disclosed |
| US-20200223821-A1 | Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 2020-07-16 | — | — | US | disclosed |
| CN-111212833-A | Novel phenylpyridine derivative and pharmaceutical composition comprising same | 株式会社大熊制药 | 2020-05-29 | — | — | CN | disclosed |
| WO-2020045941-A1 | NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 대웅제약 | 2020-03-05 | — | — | WO | disclosed |
| WO-2020045941-A1 | NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 대웅제약 | 2020-03-05 | — | — | WO | disclosed |
| WO-2019074275-A1 | NOVEL PHENYLPYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 주식회사 대웅제약 | 2019-04-18 | — | — | WO | disclosed |
| WO-2012035055-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2012-03-22 | — | — | WO | disclosed |
| WO-2012035055-A1 | NOVEL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2012-03-22 | — | — | WO | disclosed |
| WO-2011110575-A1 | DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2011-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230094404-A1 | METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES | HNMT, MAOB, PNMT | HRH3 537/4885MAPT 2398/4885SMN1; SMN2 1700/4885 |
| US-20200223821-A1 | Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same | PDCD1, PDCD5, PDCD11 | HRH3 1099/4885MAPT 1659/4885SMN1; SMN2 1892/4885 |
| US-12227498-B2 | Heterocyclic amine derivative and pharmaceutical composition comprising same | H1-5, SSB, H1-2 | HRH3 29/4885MAPT 4179/4885SMN1; SMN2 1586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.